DIAMANTI, ELEONORA
 Distribuzione geografica
Continente #
AS - Asia 133
EU - Europa 67
NA - Nord America 41
AF - Africa 2
Totale 243
Nazione #
SG - Singapore 99
US - Stati Uniti d'America 36
IT - Italia 32
CN - Cina 28
SE - Svezia 13
DE - Germania 12
CA - Canada 5
ES - Italia 4
IN - India 4
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
HK - Hong Kong 2
NL - Olanda 2
Totale 243
Città #
Singapore 90
Stockholm 13
Santa Clara 11
Bologna 9
Cagliari 5
Mississauga 5
Saarlouis 5
Barcelona 4
Hyderabad 4
Zhengzhou 3
Abidjan 2
Amsterdam 2
Bremen 2
Brno 2
Cesena 2
Florence 2
Frankfurt am Main 2
Guangzhou 2
Jinan 2
London 2
Ravenna 2
Rome 2
Solingen 2
Ashburn 1
Cambridge 1
Chengdu 1
Dongguan 1
Harbin 1
Jiaxing 1
Munich 1
Nanjing 1
Naples 1
New York 1
Prineville 1
Quanzhou 1
Shanghai 1
Shenzhen 1
Shijiazhuang 1
Taizhou 1
Wenzhou 1
Wuhan 1
Totale 193
Nome #
Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists? 50
Harnessing the 12 Green Chemistry Principles for Sustainable Antiparasitic Drugs: Toward the One Health Approach 19
Back in Person: Frontiers in Medicinal Chemistry 2023 16
Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors 15
Search for the Active Ingredients from a 2-Aminothiazole DMSO Stock Solution with Antimalarial Activity 15
Targeting the IspD Enzyme in the MEP Pathway: Identification of a Novel Fragment Class 14
Structure-Guided Optimization of Small-Molecule Folate Uptake Inhibitors Targeting the Energy-Coupling Factor Transporters 14
Identification of inhibitors targeting the energy-coupling factor (ECF) transporters 13
Bacteriomimetic Liposomes Improve Antibiotic Activity of a Novel Energy-Coupling Factor Transporter Inhibitor 13
Hit optimization by dynamic combinatorial chemistry on Streptococcus pneumoniae energy-coupling factor transporter ECF-PanT 13
DXS as a target for structure-based drug design 12
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 11
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 10
Benign-by-Design SAHA Analogues for Human and Animal Vector-Borne Parasitic Diseases 9
CD1b Tetramers Identify T Cells that Recognize Natural and Synthetic Diacylated Sulfoglycolipids from Mycobacterium tuberculosis 9
An Efficient Way to Screen Inhibitors of Energy-Coupling Factor (ECF) Transporters in a Bacterial Uptake Assay 9
Energy-Coupling Factor Transporters as Novel Antimicrobial Targets 8
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 7
Assessment of the rules related to gaining activity against Gram-negative bacteria 7
Frontiers in Medicinal Chemistry 2022 Goes Virtual 5
Might the observed α2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 5
Pyrazole-Based Acid Ceramidase Inhibitors: Design, Synthesis, and Structure-Activity Relationships 5
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement 4
Low Doses of Allyphenyline and Cyclomethyline, Effective against Morphine Dependence, Elicit an Antidepressant-like Effect 4
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 3
Target-Directed Dynamic Combinatorial Chemistry Affords Binders of Mycobacterium tuberculosis IspE 2
Targeting Plasmodium falciparum IspD in the Methyl-d-erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity 1
Totale 293
Categoria #
all - tutte 1.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202495 0 0 0 0 0 0 43 11 14 15 4 8
2024/2025198 41 81 59 17 0 0 0 0 0 0 0 0
Totale 293